Institutional Ownership Clearside Biomedical, Inc. (CLSD)
This table provides information about the institutional ownership of Clearside Biomedical, Inc. (CLSD). We have compiled data on the 9 institutions that hold shares in the stock, with a total of 3.24 Million shares, which have been reported (via 13F filing form) to have a value of $12.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
2,197,480
shares
|
$8.68 Million
3.43% of portfolio
|
Q3 2022
Reduced 3.96%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
798,137
shares
|
$3.15 Million
0.0% of portfolio
|
Q2 2024
Added 5.26%
|
|
|
Carmignac Gestion
Paris, I0 |
Nov 13, 2025 Q3 2025 |
100,556
shares
|
$397,196
0.01% of portfolio
|
Q3 2025
Reduced 93.33%
|
|
|
Northeast Financial Consultants Inc
Westport, CT |
Aug 15, 2025 Q2 2025 |
93,000
shares
|
$367,350
0.0% of portfolio
|
Q4 2023
Added 12.05%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
25,000
shares
|
$98,750
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Asset Management Corp
|
Apr 14, 2023 Q1 2023 |
14,000
shares
|
$55,300
0.01% of portfolio
|
Q1 2023
New holding
|
|
|
Apollon Wealth Management, LLC
Mount Pleasant, SC |
Oct 16, 2025 Q3 2025 |
11,793
shares
|
$46,582
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 14, 2025 Q3 2025 |
2,500
shares
|
$9,875
0.0% of portfolio
|
Q3 2025
Reduced 7.58%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|